1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Muscarinic Receptor Occupancy: new trials by email Literature Review of Muscarinic Receptor Occupancy trials Research Report on Muscarinic Receptor Occupancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor Scopolamine, [11C]EMO ([11C]LSN3172176) - Muscarinic Receptor Occupancy | Phase 1 | Withdrawn | Yale University | 2025-03-01 | 2025-05-11 |
LSN3172176 (1) · Scopolamine (1)
Yale University (1)
United States (1)